Skip to main content
OpenTrials

Clinical trial condition

Intestinal Neoplasms

Explore clinical trials studying Intestinal Neoplasms. Study availability and eligibility vary by location and protocol.

6,346 public trials 1,367 recruiting studies
Refine in advanced search Browse all conditions

Intestinal Neoplasms trial results

Active, Not Recruiting

Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment

NCT03516942

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +28 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 716 locations
View Trial Details
Active, Not Recruiting

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

NCT04291105

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colo-rectal Cancer, +25 more
Locations
  • Saint John's Health Center - John Wayne Cancer Institute (JWCI) Santa Monica, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
  • Ochsner Clinic Foundation New Orleans, Louisiana, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation

NCT05308446

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +18 more
Locations
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • Mercy Cancer Center - Carmichael Carmichael, California, United States
  • Mercy San Juan Medical Center Carmichael, California, United States
  • Kaiser Permanente Dublin Dublin, California, United States
View all 286 locations
View Trial Details
Active, Not Recruiting

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

NCT06147037

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +42 more
Locations
  • Research Site Palo Alto, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Omaha, Nebraska, United States
  • Research Site Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

NCT04083599

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +36 more
Locations
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Cancer & Blood Specialty Clinic Los Alamitos, California, United States
  • Moores Cancer Center at the UC San Diego Health San Diego, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
View all 76 locations
View Trial Details

Related conditions